• Je něco špatně v tomto záznamu ?

Effects of probiotic Escherichia coli Nissle 1917 on expression of cytochromes P450 along the gastrointestinal tract of male rats

Z. Matuskova, A. Tunkova, E. Anzenbacherova, R. Vecera, M. Siller, H. Tlaskalova-Hogenova, Z. Zidek, P. Anzenbacher

. 2010 ; 31 Suppl 2 () : 46-50.

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027176

OBJECTIVES: The aim of the study was to find whether probiotic Escherichia coli Nissle 1917 O6:K5:H1 (EcN) influences the expression of cytochromes P450 (CYP) in the rat intestine. DESIGN: Live bacterial suspension of EcN was administered to healthy male Wistar rats daily for 7 days. Control group of rats was stressed by oral application of the saline solution daily for 7 days as well. Sections of the duodenum, jejunum, ileum, caecum and colon have been taken from each experimental animal. With all individual samples, microsomal fraction has been prepared and expression of selected CYPs was determined by Western blotting. The levels of expression of CYPs were also evaluated by mRNA using real-time PCR. RESULTS: It was found that there are changes in expression of CYP enzymes studied along the intestine. CYP1A1, 2B1/2 and 2E1 are present mainly in the duodenum and jejunum; on the other hand, CYP2C6 is expressed mainly in the caecum and colon. CYP3A was found all over the rat intestine. The results show that there are no prominent differences between control samples and samples with EcN, only the expression of CYP3A protein in the duodenum appears to exhibit a clear tendency to decrease. In the case of the colon, a significant increase in the expression of CYP3A (most likely CYP3A1) after treatment of rats with EcN was found. CONCLUSION: This in vivo study revealed that the levels of colon CYP3A could be significantly increased in rats treated with probiotic EcN. On the contrary, the expression of CYP3A in the duodenum decreased. However, the changes in the expression of CYP enzymes are probably not as extensive to be clinically important in man; hence, most likely the probiotic EcN has little influence on the intestinal drug metabolism by CYP enzymes.

000      
00000naa a2200000 a 4500
001      
bmc12027176
003      
CZ-PrNML
005      
20160407182047.0
007      
ta
008      
120816s2010 sw f 000 0#eng||
009      
AR
035    __
$a (PubMed)21187832
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Rácová, Zuzana $7 xx0109661 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
245    10
$a Effects of probiotic Escherichia coli Nissle 1917 on expression of cytochromes P450 along the gastrointestinal tract of male rats / $c Z. Matuskova, A. Tunkova, E. Anzenbacherova, R. Vecera, M. Siller, H. Tlaskalova-Hogenova, Z. Zidek, P. Anzenbacher
520    9_
$a OBJECTIVES: The aim of the study was to find whether probiotic Escherichia coli Nissle 1917 O6:K5:H1 (EcN) influences the expression of cytochromes P450 (CYP) in the rat intestine. DESIGN: Live bacterial suspension of EcN was administered to healthy male Wistar rats daily for 7 days. Control group of rats was stressed by oral application of the saline solution daily for 7 days as well. Sections of the duodenum, jejunum, ileum, caecum and colon have been taken from each experimental animal. With all individual samples, microsomal fraction has been prepared and expression of selected CYPs was determined by Western blotting. The levels of expression of CYPs were also evaluated by mRNA using real-time PCR. RESULTS: It was found that there are changes in expression of CYP enzymes studied along the intestine. CYP1A1, 2B1/2 and 2E1 are present mainly in the duodenum and jejunum; on the other hand, CYP2C6 is expressed mainly in the caecum and colon. CYP3A was found all over the rat intestine. The results show that there are no prominent differences between control samples and samples with EcN, only the expression of CYP3A protein in the duodenum appears to exhibit a clear tendency to decrease. In the case of the colon, a significant increase in the expression of CYP3A (most likely CYP3A1) after treatment of rats with EcN was found. CONCLUSION: This in vivo study revealed that the levels of colon CYP3A could be significantly increased in rats treated with probiotic EcN. On the contrary, the expression of CYP3A in the duodenum decreased. However, the changes in the expression of CYP enzymes are probably not as extensive to be clinically important in man; hence, most likely the probiotic EcN has little influence on the intestinal drug metabolism by CYP enzymes.
650    _2
$a zvířata $7 D000818
650    _2
$a aromatické hydroxylasy $x metabolismus $7 D001189
650    _2
$a kolon $x enzymologie $7 D003106
650    _2
$a cytochrom P-450 CYP3A $x metabolismus $7 D051544
650    _2
$a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
650    _2
$a duodenum $x enzymologie $7 D004386
650    _2
$a Escherichia coli $7 D004926
650    _2
$a gastrointestinální trakt $x enzymologie $7 D041981
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a modely u zvířat $7 D023421
650    _2
$a probiotika $x farmakologie $7 D019936
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Tunková, Alena $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, 775-15 Czech Republic $7 xx0108067
700    1_
$a Anzenbacherová, Eva, $d 1959- $7 stk2008428613 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, 775-15 Czech Republic
700    1_
$a Večeřa, Rostislav, $d 1965- $7 mzk2004236742
700    1_
$a Šiller, Michal $7 xx0109663 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, 775-15 Czech Republic
700    1_
$a Tlaskalová, Helena, $d 1938- $7 jn20000402365 $u Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Zídek, Zdeněk $7 jk01152582 $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic
700    1_
$a Anzenbacher, Pavel, $d 1947- $7 xx0034447 $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, 775-15 Czech Republic
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 31 Suppl 2(2010), s. 46-50
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21187832 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160407181809 $b ABA008
999    __
$a ok $b bmc $g 949218 $s 784522
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 31 Suppl 2 $d 46-50 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$b NLK112 $a Pubmed-20120816/11/02

Najít záznam

Citační ukazatele

    Možnosti archivace